Efavirenz (HIV Drug) case: Bristol (BMS) won over Mylan Pharma

Bristol Meyers Squibb (BMS), manufacturers of Efavirenz (patented drug for HIV) won over the companies named Mylan Pharmaceuticals Inc. and Mylan Laboratories Ltd. that made generic version of Efavirenz that is Sustiva. The companies filed an application in court for the permission to manufacture and sell Sustiva before the patent granted for Efavirenz …

Victory of Generic Companies: Benefit to Consumers

Conflicts between the innovators and generic companies have increased to a great extent and the latest example of the same is the one between Novartis and Merck-Glenmark. These conflicts came into picture when Mylan filed an Abbreviated New Drug Application (ANDA) for the generic version of Copaxone which is produced by Teva pharmaceuticals and accounts …